Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
about
Galactomannan detection for invasive aspergillosis in immunocompromised patientsGalactomannan detection for invasive aspergillosis in immunocompromized patientsβ-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3)Infections after orthotopic liver transplantationStructural Insights into Recognition of Triple-helical -Glucans by an Insect Fungal ReceptorInvasive aspergillosis in the intensive care unitComparative evaluation of (1, 3)-beta-D-glucan, mannan and anti-mannan antibodies, and Candida species-specific snPCR in patients with candidemia.Successful combination of antifungal agents and surgical resection for pulmonary aspergillosis in a child with Hodgkin disease: review of the literature.Performance of a Quantitative PCR-Based Assay and Beta-D-Glucan Detection for the Diagnosis of Invasive Candidiasis in Very Low Birth Weight Preterm Neonatal Patients (CANDINEO Study).The era of molecular and other non-culture-based methods in diagnosis of sepsisLevels of (1→3)-β-D-glucan, Candida mannan and Candida DNA in serum samples of pediatric cancer patients colonized with Candida speciesDevelopment of a novel inhalational model of invasive pulmonary aspergillosis in rats and comparative evaluation of three biomarkers for its diagnosis.Use and limits of (1-3)-β-d-glucan assay (Fungitell), compared to galactomannan determination (Platelia Aspergillus), for diagnosis of invasive aspergillosis.Alzheimer's disease and disseminated mycoses.Early Diagnosis of Invasive Aspergillosis in Neutropenic Patients. Comparison between Serum Galactomannan and Polymerase Chain Reaction.Fungal diagnostics in pneumoniaBloodstream infections are an improbable cause of positive serum (1,3)-β-D-glucan in hematology patients.β-D-Glucan Assay in Diagnosis and Monitoring the Systemic Candidiasis in a Rat Model.The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Beta-D-glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based studyDiagnostic accuracy of serum 1,3-β-D-glucan for pneumocystis jiroveci pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and meta-analysis.Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis.Diagnosis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-2)The Screening Performance of Serum 1,3-Beta-D-Glucan in Patients with Invasive Fungal Diseases: A Meta-Analysis of Prospective Cohort StudiesAudit of laboratory mycology services for the management of patients with fungal infections in the northwest of England.Serum galactomannan and (1->3)-β-D-glucan assays for patients with multiple myeloma and Waldenstrom's macroglobulinemia.Aspergillus Polymerase Chain Reaction: Systematic Review of Evidence for Clinical Use in Comparison With Antigen Testing.(1-3)-β-D-Glucan vs Galactomannan Antigen in Diagnosing Invasive Fungal Infections (IFIs)Fungal infections: their diagnosis and treatment in transplant recipients.Molecular diagnosis of invasive mycoses of the central nervous system.Management of Pneumocystis jirovecii Pneumonia in Kidney Transplantation to Prevent Further Outbreak.Evaluation of the role of real-time PCR in the diagnosis of invasive aspergillosis.Contribution of the (1-->3)-beta-D-glucan assay for diagnosis of invasive fungal infections.Improved detection of circulating Aspergillus antigen by use of a modified pretreatment procedureAntigen detection, serology, and molecular diagnosis of invasive mycoses in the immunocompromised host.Diagnostic methods for invasive fungal diseases in patients with hematologic malignanciesInvasive fungal infections in acute leukemia.Post-diagnostic kinetics of the (1 → 3)-β-D-glucan assay in invasive aspergillosis, invasive candidiasis and Pneumocystis jirovecii pneumoniaDevelopment of an immunochromatographic lateral-flow device for rapid serodiagnosis of invasive aspergillosis.
P2860
Q24186895-FEA0C89D-54F4-459A-AD9D-04E5B4FCFB4FQ24240734-ECD53529-4497-415A-ABE2-5DBD6FD07CCBQ26825753-E12DCCFF-D282-4F5D-A980-EED24537154EQ27023182-A3A4E5CF-FCB0-489D-B8B9-D97B479872C4Q27670513-B88AFCFC-8844-4B5C-88EB-4A1826E1E731Q28306909-D9986438-9C5A-4F6A-841C-CC98C3AB705DQ33296907-3D7E887E-2E00-4826-8552-84158DA220F9Q33377864-85AC63AD-96E8-47C0-A472-672CFB8A9266Q33443072-45CAE6EB-7716-4C2B-BE5B-BB3971B03A92Q33591270-CEFEABE4-02EB-4620-BDB4-58D91D83A3B9Q33711043-24C8E798-92CD-46AE-81F3-5DC9694143BBQ33793571-0B9FF76F-3D9C-4EE1-A044-7DA4452943BEQ33900089-CB7EEC2E-B304-4AB6-A7ED-85349455C843Q34039644-9B239A48-16C5-4812-813B-1F7A1735D2D7Q34052696-37B13525-8CA2-430F-A527-16ADE292A3CDQ34153565-07422DCF-978C-4827-A98C-EC46E937BB15Q34260841-87B1B04D-6230-4468-BFD1-8EC9A4120163Q34443501-0A4C7107-905D-4367-8822-90CA15970CBDQ34489333-102CB6ED-C051-4CF4-B600-769B2B0269DBQ34532546-706932A8-8094-407B-8598-367E4D0C0ED6Q35530416-1BF5745C-5772-4241-8A1A-8B9C6A55848DQ35668212-BD8BFD0F-5280-4658-A48A-06C5983E4A6EQ35672970-00877AB0-CB47-418D-A693-AC4F3D1ECABCQ35678921-BD81577A-B49D-4078-9B75-4A543D64C757Q35683091-D6E0727A-9FB6-4509-BBBB-E477DB95CD88Q35770150-439D1C90-1D4E-4C4F-A54C-4B16E6F5C9F3Q35806943-C40479EF-8078-462F-ACCA-894FCCDA2279Q36094242-806FDA4F-90C2-4372-8F9C-717BC8F4D59AQ36201457-744D6BD8-7504-45CC-8392-3FFA3A29B79AQ36206568-6C9CA7C4-7A9C-46C3-8879-282CF8A3ECFBQ36218994-9F878E17-2316-47ED-8FB1-9D83A4135362Q36288984-85687B53-3DA5-4A4F-80EC-8FE8D02D2C85Q36328419-92937B24-1D92-40BB-BE6F-16F276EF4976Q36497847-5996413A-44BB-42D5-B461-38C9ACBBA022Q36539727-90B0D2DE-7390-453A-93A7-AABE92BAD12DQ36567799-CC71419A-4C1F-4EAB-8BA7-803B7FAC57B0Q36584898-06ECFD3A-3944-401C-83A2-B911A21EC1E4Q36612597-009F1192-D7E3-40F8-9186-5835A4E34746Q36744771-B0B8C266-3A5E-49D3-AB6C-5BB2C7966DE6Q36746929-EA036C2B-21E4-4E64-9FA1-B6272A92DF26
P2860
Contribution of (1->3)-beta-D-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Contribution of (1->3)-beta-D- ...... for circulating galactomannan.
@ast
Contribution of (1->3)-beta-D- ...... for circulating galactomannan.
@en
type
label
Contribution of (1->3)-beta-D- ...... for circulating galactomannan.
@ast
Contribution of (1->3)-beta-D- ...... for circulating galactomannan.
@en
prefLabel
Contribution of (1->3)-beta-D- ...... for circulating galactomannan.
@ast
Contribution of (1->3)-beta-D- ...... for circulating galactomannan.
@en
P2093
P2860
P1476
Contribution of (1->3)-beta-D- ...... for circulating galactomannan.
@en
P2093
Amalia Del Palacio
Carmen Pazos
José Pontón
P2860
P304
P356
10.1128/JCM.43.1.299-305.2005
P407
P577
2005-01-01T00:00:00Z